BPC-157 vs Ipamorelin
A comprehensive, data-driven comparison of BPC-157 (Body Protection Compound-157) and Ipamorelin (NNC 26-0161). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | BPC-157 Body Protection Compound-157, PL 14736 | Ipamorelin NNC 26-0161 |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Category 2 (pending reclassification) |
| Category | Recovery & Healing | Growth Hormone |
| Primary Use | Tissue healing and injury recovery | Growth hormone optimization |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $50 - $120/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 250-500mcg daily | 200-300mcg 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth factors, and accelerates tissue repair | Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH release without affecting cortisol or prolactin |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Ipamorelin is generally more affordable ($35 - $70/mo) compared to BPC-157 ($50 - $120/mo).
- 2BPC-157 has low-quality evidence, while Ipamorelin has emerging-quality evidence.
- 3They belong to different categories: BPC-157 (Recovery & Healing) vs Ipamorelin (Growth Hormone).
Which Is Better For...
Ipamorelin
More budget-friendly option with lower monthly costs
BPC-157
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| BPC-157 | $50 - $120/mo | Category 2 (pending reclassification) | Various research labs |
| Ipamorelin | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
BPC-157 works via Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth. Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. They differ in FDA approval status, efficacy data, and cost.
BPC-157 typically costs $50 - $120/mo, while Ipamorelin costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
BPC-157 is not FDA-approved (Category 2 (pending reclassification)). Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of BPC-157 include Injection site discomfort, Mild headache, Dizziness. Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
BPC-157 is a synthetic peptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. Although not FDA-approved, it has gained significant attention in research a...
View Full BPC-157 GuideIpamorelin is a pentapeptide that selectively stimulates growth hormone release by mimicking ghrelin, the hunger hormone. Unlike many other GH secretagogues, ipamorelin does not significantly increase...
View Full Ipamorelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between BPC-157 and Ipamorelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.